2022
DOI: 10.1016/j.suronc.2022.101804
|View full text |Cite
|
Sign up to set email alerts
|

Primary and recurrent regional metastases for lateralized oral cavity squamous cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 54 publications
0
2
0
Order By: Relevance
“…This study is the first to evaluate the laterality of LVI in PCa and its correlation with the lateralization of nodal involvement. While the impact of LVI on lateralized LNI has been explored in various malignancies such as thyroid, oropharyngeal, and rectal cancers, the specific investigation of LVI laterality in the setting of PCa has not been previously undertaken [ 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 ]. Existing studies have primarily focused on the broader question of whether LVI influences lateralized LNI, omitting an in-depth exploration of LVI laterality itself [ 22 , 23 ].…”
Section: Discussionmentioning
confidence: 99%
“…This study is the first to evaluate the laterality of LVI in PCa and its correlation with the lateralization of nodal involvement. While the impact of LVI on lateralized LNI has been explored in various malignancies such as thyroid, oropharyngeal, and rectal cancers, the specific investigation of LVI laterality in the setting of PCa has not been previously undertaken [ 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 ]. Existing studies have primarily focused on the broader question of whether LVI influences lateralized LNI, omitting an in-depth exploration of LVI laterality itself [ 22 , 23 ].…”
Section: Discussionmentioning
confidence: 99%
“…Surgery is the primary treatment of OSCC, followed by cisplatin-based chemotherapy and/or radiotherapy depending on pathologic features and individualized risk of recurrence. Regional recurrence is the most common cause of failure after treatment of oral carcinoma ( 2 , 3 ). Despite advancements in surgical techniques and adjuvant therapies, the 5-year overall survival rate hovers between 45-50%, contingent upon the stage and metastasis status of the disease ( 4 , 5 ).…”
Section: Introductionmentioning
confidence: 99%